The current financial score of Aspen Aerogels Inc is 6.54. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 49.85M, representing a year-over-year decrease of 36.11%, while its net profit experienced a year-over-year decrease of 156.89%.
The current valuation score of Aspen Aerogels Inc is 5.87. Its current P/E ratio is -3.76, which is -296879.88% below the recent high of 11169.01 and -1792.73% above the recent low of -71.23.
The current earnings forecast score of Aspen Aerogels Inc is 7.00. The average price target is 7.75, with a high of 10.00 and a low of 5.00.
The current price momentum score of Aspen Aerogels Inc is 4.15. Currently, the stock price is trading between the resistance level at 5.41 and the support level at 4.72, making it suitable for range-bound swing trading.
The current institutional shareholding score of Aspen Aerogels Inc is 7.00. The latest institutional shareholding proportion is 71.04%, representing a quarter-over-quarter decrease of 29.71%. The largest institutional shareholder is Chuck Royce, holding a total of 1.32M shares, representing 0.07% of shares outstanding, with 38.10% increase in holdings.
The current risk assessment score of Aspen Aerogels Inc is 2.53. The company's beta value is 2.99. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.